Zwart, Koen
van Nassau, Sietske C. M. W.
van der Baan, Frederieke H.
Koopman, Miriam http://orcid.org/0000-0003-1550-1978
Snaebjornsson, Petur http://orcid.org/0000-0002-1086-8108
van Gestel, Anna J.
Vink, Geraldine R.
Roodhart, Jeanine M. L. http://orcid.org/0000-0003-1398-8970
Article History
Received: 24 July 2023
Revised: 30 April 2024
Accepted: 1 May 2024
First Online: 20 May 2024
Competing interests
: KZ: Received research funding via institution from Bristol-Myers Squibb. SN: Received research funding via institution from Pierre-Fabre. Had travel, accommodations, or other expenses paid or reimbursed via institution by Servier. FB: Received research funding via institution from Bristol-Myers Squibb. MK: Received research funding via institution from Bayer, Bristol-Myers Squibb, Merck-Serono, Pierre Fabre, Servier, Roche, Sanofi, and Personal Genome Diagnostics. PS: Consulting or advisory role for Bayer, Bristol-Myers Squibb, MEDtalks via institution. AG: No competing interests. GV: Consulting or advisory role for Merck via institution. Received research funding via institution from Merck, Bayer, Personal Genome Diagnostics, Delphi Diagnostics, Bristol-Myers Squibb, Sirtex Medical. JR: Consulting or advisory role for Bayer, Bristol-Myers Squibb, Merck-Serono, Pierre Fabre, Servier via institution. Received research funding via institution from Bayer, Bristol-Myers Squibb, Merck-Serono, Pierre Fabre, Servier, HUB 4 organoids, and Cleara Biotech. Had travel, accommodations, or other expenses paid or reimbursed via institution by Servier.
: According to the Central Committee on Research involving Human Subjects, this type of registry-based study does not require approval from an ethics committee in the Netherlands. The study was approved by the Privacy Review Board and the scientific council of the Netherlands Comprehensive Cancer Organization (IKNL) which collects and guards the data for the Netherlands Cancer Registry (NCR). All data were pseudonymized prior to the transfer from IKNL to the researchers. The NCR uses an opt-out approach to consent. The study was performed in accordance with the Declaration of Helsinki.